Indoleamine 2,3-dioxygenase-1 (IDO-1), a rate-limiting enzyme of kynurenine biogenesis, was proved to be a novel therapeutic target for post-vascular injury thrombosis in chronic kidney disease (CKD) [37]. Here, IDO1 is linked to chronic kidney disease.